Neohesperidin dihydrochalcone
Neohesperidin dihydrochalcone (NHDC) is a type of artificial sweetener derived from citrus fruits. It is particularly known for its intense sweetness, which is estimated to be approximately 1500-1800 times sweeter than sugar.
History[edit]
NHDC was first discovered in 1963 by the United States Department of Agriculture. It was initially used as a means of reducing the bitterness of certain foods and beverages, but its intense sweetness was soon recognized and it began to be used as a sugar substitute.
Production[edit]
The production of NHDC involves the extraction of neohesperidin from the bitter orange, a type of citrus fruit. This is then hydrogenated to form NHDC. The process is complex and requires a high level of expertise in biochemistry and food science.
Uses[edit]
NHDC is used in a wide range of products, including confectionery, beverages, dairy products, and baked goods. It is also used in some pharmaceutical products due to its ability to mask bitter tastes. In addition to its use as a sweetener, NHDC has been found to have antioxidant properties, which may contribute to its potential health benefits.
Safety and regulation[edit]
NHDC is generally recognized as safe (GRAS) by the Food and Drug Administration (FDA) in the United States. It is also approved for use in the European Union and many other countries around the world. However, like all artificial sweeteners, it is subject to regulation and its use is monitored to ensure it does not pose a risk to public health.
See also[edit]
References[edit]
-
Neohesperidin dihydrochalcone
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
